Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Betamethasone sodium phosphate [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone sodium phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone sodium phosphate 1 mg/g eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone sodium phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone sodium phosphate [ear] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone sodium phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone sodium phosphate [nose] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone sodium phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely betamethasone sodium phosphate 1 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone sodium phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone sodium phospha 4mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone sodium phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone sodium phospha 15mg/5mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone sodium phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone sodium phospha 3mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone sodium phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone acetate + betamethasone sodium phosphate 3mg/3mg per mL injection suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone sodium phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone acetate + betamethasone sodium phospha 3mg/ns soluspan |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone sodium phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone sodium phosphate preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone sodium phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone sodium phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone sodium phosphate 4mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone sodium phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
bétaméthasone 4 mg/mL, ampoule de 1 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone sodium phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone sodium phospha 3mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone sodium phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betamethasone sodium phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely betamethasone sodium phosphate 1 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) |
Has precise active ingredient |
True |
Betamethasone sodium phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely betamethasone sodium phosphate 1 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) |
Has basis of strength substance (attribute) |
True |
Betamethasone sodium phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betamethasone sodium phosphate 1 mg/g eye ointment |
Has precise active ingredient |
True |
Betamethasone sodium phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betamethasone sodium phosphate 1 mg/g eye ointment |
Has basis of strength substance (attribute) |
True |
Betamethasone sodium phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance) |
Has precise active ingredient |
True |
Betamethasone sodium phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance) |
Has basis of strength substance (attribute) |
True |
Betamethasone sodium phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops |
Has precise active ingredient |
False |
Betamethasone sodium phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely betamethasone (as betamethasone sodium phosphate) 4 milligram/1 milliliter conventional release solution for injection ampule |
Has precise active ingredient |
False |
Betamethasone sodium phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely betamethasone (as betamethasone sodium phosphate) 4 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Betamethasone sodium phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops |
Has precise active ingredient |
True |
Betamethasone sodium phosphate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |